BIOVIE INC

For the period ended Jun 30, 2024. Filed Sep 30, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Sep 30, 2024

BIVI$1.30-2.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Cover page Item 16. Form 10-K Summary

PART I

Item 1. Business Item 1A. Risk Factors Item 1B. Unresolved Staff Comments Item 1C. Cybersecurity Item 2. Properties Item 3. Legal Proceedings Item 4. Mine Safety Disclosures

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Item 6. [Reserved] (no text here)

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Item 7A. Quantitative and Qualitative Disclosures About Market Risk (no text here)

Item 8. Financial Statements and Supplementary Data Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure Item 9A. Controls and Procedures Item 9B. Other Information

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections (no text here)

PART III

Item 10. Directors, Executive Officers and Corporate Governance (no text here)

Item 11. Executive Compensation (no text here)

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters (no text here)

Item 13. Certain Relationships and Related Transactions, and Director Independence (no text here)

Item 14. Principal Accountant Fees and Services (no text here)

PART IV

Item 15. Exhibits and Financial Statement Schedules Indicates a management contract or compensatory plan or arrangement Report of Independent Registered Public Accounting Firm – EisnerAmper LLP (PCAOB Number 274)Balance Sheets Statements of Operations and Comprehensive Loss Statements of Changes in Stockholders’ Equity Statements of Cash Flows Notes to Financial Statements

Statements of Operations and Comprehensive Loss

	Year ended	Year ended
	June 30, 2024	June 30, 2023
OPERATING EXPENSES:
Amortization of intangible assets	$229,377	$229,377
Research and development expenses	23,100,394	33,299,503
Selling, general and administrative expenses	8,849,814	11,551,568
TOTAL OPERATING EXPENSES	32,179,585	45,080,448
LOSS FROM OPERATIONS	(32,179,585)	(45,080,448)
OTHER (INCOME) EXPENSE:
Change in fair value of derivative liabilities	(1,816,271)	1,437,481
Interest expense	2,893,922	4,300,150
Interest income	(1,136,703)	(562,264)
TOTAL OTHER (INCOME) EXPENSE, NET	(59,052)	5,175,367
NET LOSS	$(32,120,533)	$(50,255,815)
Deemed dividend related to ratchet adjustment to warrants	886,423	-
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	$(33,006,956)	$(50,255,815)
NET LOSS PER COMMON SHARE
- Basic	$(7.30)	$(15.47)
- Diluted	$(7.30)	$(15.47)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING
- Basic	4,518,533	3,248,349
- Diluted	4,518,533	3,248,349
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	$(33,006,956)	$(50,255,815)
Other comprehensive (loss) income
Unrealized gain on available-for-sale investments	-	176,591
Reclassification of unrealized gains on available-for-sale investments upon settlement	(176,591)	-
Total other comprehensive (loss) income	(176,591)	176,591
Comprehensive loss	$(33,183,547)	$(50,079,224)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.